FDA Inspection 1123031 — Thymoorgan Pharmazie Gmbh

Thymoorgan Pharmazie Gmbh — FEI 3002320821

The FDA completed an inspection of Thymoorgan Pharmazie Gmbh on June 20, 2019 in Goslar. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 20, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Goslar (Germany)

Additional Details

Mutual Recognition Agreement (MRA)